Advertisement
News
Subscribe to MDT Magazine News

Summary Box: UnitedHealth 1Q profit climbs 13 pct

April 21, 2011 9:45 am | by The Associated Press | Comments

QUARTERLY GROWTH: UnitedHealth Group Inc. said Thursday it earned $1.35 billion, or $1.22 per share, in the first quarter. That's up from $1.19 billion, or $1.03 per share, in the same quarter last year. Revenue rose 10 percent to $25.43 billion.WALL STREET EXPECTATIONS: Analysts surveyed by...

Massachusetts, South Korea heat up ties in life sciences

April 21, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Massachusetts and South Korean government officials met this week seeking to deepen collaborations in life sciences, high tech and other areas, including signing a three-year memorandum of understanding. A second meeting, which included Boston-based Oxford Bioscience Partners, which...

InfraReDx gets European CE approval for coronary imaging system

April 21, 2011 9:37 am | by Mass High Tech: The Journal of New England Technology | Comments

InfraReDx Inc. of Burlington has received CE mark approval in Europe to start commercializing its LipiScan IVUS Coronary Imaging System. The company received 510(k) medical device clearance from the U.S. Food and Drug Administration for the product in 2010.

Advertisement

iMD Companies, Inc. Acquires OMI LLC and Files Financials for 2010(2)

April 21, 2011 8:37 am | by Bio-Medicine.Org | Comments

TAMPA, Fla., April 21, 2011 /- iMD Companies (ICBU.PK) is pleased to announce that is has acquired an Independent Diagnostic Testing Facility (IDTF), Optimum Mobile Imaging LLC, which increases and diversifies the Company's portfolio of Medical Service businesses.  The acquisition...

TOPICS:

Scott & White Healthcare Broadcasts Live Surgery to Sao Paolo, Brazil

April 21, 2011 8:35 am | by Bio-Medicine.Org | Comments

TEMPLE, Texas, April 21, 2011 /- Scott & White Healthcare today teleconferenced one of the world's first live international surgical procedures to repair an abdominal aortic aneurysm to conference attendees in Sao Paolo, Brazil. The meeting, CICE (Current Issues in Comparative...

TOPICS:

FDA Grants Orphan Drug Designation for Nektar's Investigational Drug, NKTR-102, for Treatment of Women with Ovarian Cancer

April 21, 2011 8:34 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, April 21, 2011 /- Nektar Therapeutics (Nasdaq: NKTR ) today announced that the company's oncology drug candidate, NKTR-102, has been granted orphan drug status for the treatment of women with ovarian cancer by the U.S. Food and Drug Administration (FDA). "This designation...

TOPICS:

New Published Study Finds Masimo Noninvasive SpCO Effective for Screening Emergency Department Patients for Carbon Monoxide Poisoning

April 21, 2011 8:34 am | by Bio-Medicine.Org | Comments

IRVINE, Calif., April 21, 2011 /- Masimo (NASDAQ: MASI ) announced today that a new study published in this month's issue of the peer-reviewed journal, Annals of Emergency Medicine, demonstrates that noninvasive Masimo carboxyhemoglobin (SpCO®) measurements provide an "effective...

TOPICS:

Caliper Life Sciences to Present at the 36th Annual Deutsche Bank Health Care Conference

April 21, 2011 8:34 am | by Bio-Medicine.Org | Comments

HOPKINTON, Mass., April 21, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that Kevin Hrusovsky, Caliper's President and CEO, will present at the 36th Annual Deutsche Bank Health Care Conference in Boston on May 2, 2011 at 10:40 a.m. ET. A live webcast of the...

TOPICS:
Advertisement

iMD Companies, Inc. Acquires OMI LLC and Files Financials for 2010

April 21, 2011 8:33 am | Comments

TAMPA, Fla., April 21, 2011 /- iMD Companies (ICBU.PK) is pleased to announce that is has acquired an Independent Diagnostic Testing Facility (IDTF), Optimum Mobile Imaging LLC, which increases and diversifies the Company's portfolio of Medical Service businesses.  The acquisition...

Cepheid swings to profit in 1st quarter

April 21, 2011 7:45 am | by The Associated Press | Comments

Shares of molecular diagnostics company Cepheid were flat Thursday despite stronger-than-expected quarterly results.THE SPARK: The Sunnyvale, Calif., company reported a profit of $527,000, or a penny per share, in the first quarter of 2011. A year ago Cepheid took a loss of $4.3 million, or 7...

Baxter International reports 1Q profit

April 21, 2011 7:45 am | by The Associated Press | Comments

Drug and medical device maker Baxter International Inc. on Thursday reported a profit in the first quarter on a mix of higher sales and lower costs, and the company boosted its full-year financial outlook.The company earned $577 million, or 98 cents per share, compared with a loss of $60...

Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder

April 21, 2011 6:35 am | by Bio-Medicine.Org | Comments

BRANFORD, Conn., April 21, 2011 /- Marinus Pharmaceuticals, Inc., the leader in the development of neurosteroids for central nervous system disorders, today announced commencement of a proof-of-concept clinical trial of its lead candidate ganaxolone for the treatment of posttraumatic...

TOPICS:

Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association

April 21, 2011 6:35 am | by Bio-Medicine.Org | Comments

RENO, Nev., April 21, 2011 /- Sanare, LLC, a leading provider of care management solutions for people with diabetes, and its new consumer brand, BrightSky, have become National Strategic Partners of the American Diabetes Association.® (Logo:...

TOPICS:

ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®

April 21, 2011 6:34 am | by Bio-Medicine.Org | Comments

IRVINGTON, N.Y., April 21, 2011 /- ORTHOCON, Inc., a privately-held therapeutic device company, today announced that DEKRA and Health Canada have cleared its HEMA SORB Absorbable Bone Hemostat Matrix for clinical use and sale in Europe and Canada. HEMA SORB is a ready-to-use,...

TOPICS:

Amgen says it will pay dividend starting in 2Q

April 21, 2011 5:45 am | by The Associated Press | Comments

Biotechnology company Amgen Inc. says it will start paying a quarterly dividend in the second quarter, and plans to pay about 20 percent of its adjusted annual profit in dividends.The Thousand Oaks, Calif., company had been expected to declare its first dividend. It says it will raise its...

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading